Tag: physical sciences
-

Trial Shows Wearable Device Can Reduce Migraine
Results from a clinical trial show an electronic device worn on the arm can reduce migraine occurrences in people with history of the condition.
-

Hydrogel Biomaterials Company Raises $3M in Early Funds
A developer of bioactive hydrogels as alternatives to animal models for drug discovery and clinical lab tests is raising $3 million in its first venture round.
-

Start-Up to Manufacture, Supply Practical Radiation Drugs
A new company formed by a technology venture investor and the Mayo Clinic aims to produce and supply more readily available radiation drug therapies.
-

Drug Licensed for Precision Autism Spectrum Therapies
A company making precision therapies for neurological disorders is acquiring rights to a compound first designed as a treatment for cancer, inflammation, and oxidative stress.
-

Nasal Spray Vaccines Get CEPI, NIH Funding
A developer of infectious disease vaccines is gaining funds for new nasal sprays protecting against a range of coronaviruses and the sexually-transmitted disease gonorrhea.
-

Algae-Grown Non-Needle Malaria Vaccine in Preclinical Test
A vaccine grown in genetically-altered algae, designed as a nasal-spray and edible drug, is shown to protect lab mice against parasite infections causing malaria.
-

Start-Up Developing Efficient RNA Process, Raises $12M
A company formed earlier this year is commercializing a more efficient process for making synthetic RNA molecules and raising $12 million in seed funds.
-

Stem Cell Lab Planned for Commercial Space Station
A collaboration between university researchers and a space science company is designing a stem cell research lab on a proposed commercial space station.
-

Company Formed to Boost Clinical Trial Success Odds
A pharma/tech industry group is starting a new company to use algorithms for finding gaps in preclinical data that can impair clinical trial progress.
-

Start-Up Licenses Gene-Edited Drug Discovery Tech.
A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases.